Chemical Structure (Myqorzo 01)
Myqorzo Tablet, Film Coated
Product Images NDC 82112-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Myqorzo (NDC 82112-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cytokinetics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Myqorzo 02)
This text appears to be a tabulated data set likely related to a clinical trial or medical study. It contains information on various parameters such as gender, age group, baseline BMI, NYHA class, left ventricular ejection fraction, CPET modality, beta blocker use, sarcomeric gene mutation status, and more, for patients in a study group and a placebo group. The dataset includes values for the number of patients in each category, as well as comparisons between MYQORZO and Placebo groups in terms of LSM differences along with their corresponding confidence intervals. The data might be used to analyze the effects of a specific intervention or treatment on patients with certain medical conditions.*
Figure 2 (Myqorzo 03)
Figure 3 (Myqorzo 04)
Principal Display Panel (5 mg Tablet Bottle Label)
This text is not readable.*
Principal Display Panel (10 mg Tablet Bottle Label)
This text is providing information about a medication with the NDC code 82112-110-30 containing aficamten 10 mg per tablet. It also gives recommendations for storing the tablets between 20°C to 25°C (68°F to 77°F). The medication is distributed by Cytokinetics Inc. and comes in a pack of 30 tablets.*
Principal Display Panel (15 mg Tablet Bottle Label)
Each tablet contains aficamten 15 mg. Recommended dosage is not available. Store at 20°C to 25°C (68°F to 77°F) and keep out of reach of children. The medication is distributed by a company named CORINGcs®. Each box contains 30 tablets.*
Principal Display Panel (20 mg Tablet Bottle Label)
This text contains information about a medication called aficamten, with each tablet having a dosage of 20 mg. The recommended dosage is not available. The manufacturer is Cytokinetics®, located in South San Francisco, CA 94080. The storage instructions indicate to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The lot number is 12345678. The expiration date is indicated in the format YYYY-MM. The text also mentions information about dispensing the medication with attached information. The NDC code is 82112-120-30.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
